Bagmane Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 1987 in Bangalore, Karnataka, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U02423KA1987PTC008494. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹0.83 M.
It upholds a compliant status. Its leadership includes Dandiganahalli Ramakrishna Venkataramanappa (Director), Raja Bagmane (Director), Danasale Ramegowda Pradeepa (Additional Director). Past directors included Raja Bagmane, Nagamani Raja. Its latest AGM occurred on 30 August 2024, with the balance sheet filed on 31 March 2024. It is based at Lakeviewbuilding,No.66/1-4,Ablock8Thfloor,Bagmanetechpark,C.V.Rama, N Nagar, Bangalore, Karnataka, 560097.
U02423KA1987PTC008494
008494
20 July 1987
₹2.00 Cr
₹0.83 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Bagmane Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dandiganahalli Ramakrishna Venkataramanappa | Director | 15 Feb 2010 | Current |
| Raja Bagmane | Director | 20 Jul 1987 | Current |
| Danasale Ramegowda Pradeepa | Additional Director | 25 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 05 Aug 2022 | Past |
| Pramod Abcsdd | Director | 28 Mar 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bagmane Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 82.81% decrease. The company also saw a substantial improvement in profitability, with a 49.88% increase in profit. The company's net worth dipped by a decrease of 6.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Bagmane Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Bagmane Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bagmane Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bagmane Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Danasale Ramegowda Pradeepa was appointed as a Additional Director was appointed as a Additional Director on 25 Apr 2025 & has been associated with this company since 7 months 8 days . was completed.
Progress on Bagmane Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Aug 2024 as per latest MCA records. was documented.
Bagmane Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Dandiganahalli Ramakrishna Venkataramanappa was appointed as a Director was appointed as a Director on 15 Feb 2010 & has been associated with this company since 15 years 9 months . was recorded as a recent event.
Raja Bagmane was appointed as a Director was appointed as a Director on 20 Jul 1987 & has been associated with this company since 38 years 4 months . was recorded as a recent event.
Bagmane Pharmaceuticals Private Limited was registered on 20 Jul 1987 with Roc Bangalore & aged 38 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Bagmane Pharmaceuticals Private Limited is U02423KA1987PTC008494.
Bagmane Pharmaceuticals Private Limited is headquartered at Lakeviewbuilding,No.66/1-4,Ablock8Thfloor,Bagmanetechpark,C.V.Rama, N Nagar, Bangalore, Karnataka, 560097.
Bagmane Pharmaceuticals Private Limited was incorporated on 20 July 1987.
The current directors of Bagmane Pharmaceuticals Private Limited are
The primary industry of Bagmane Pharmaceuticals Private Limited is Pharma.
Bagmane Pharmaceuticals Private Limited is unlisted.
The authorized capital of Bagmane Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹0.83 M.
The compliance status of Bagmane Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX